Intravenous Iron in Gynecologic Cancer Patients Receiving Chemotherapy

• Status: Completed
• Trial end date: 2012-11-01
• Target enrollment: 0
• Participant gender: Female

Summary

Can intravenous iron lower the rate of blood transfusion in gynecologic cancer patients receiving platinum based chemotherapy than oral iron?

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Chulalongkorn University
• Treatments: Ferric Oxide, Saccharated; Iron

Criteria

Inclusion Criteria:

• Age 20-70 years

• Good performance status (Zubrod score < 2)

• No serious underlying disease

• Normal renal function test

• Normal liver function test

• Platinum based chemotherapy is the first line regimen

• No prior or receiving radiotherapy

Exclusion Criteria:

• Iron hypersensitivity

• Underlying disease which has the risk of iron overload such as chronic kidney disease, major thalassemia

• Progressive disease

• Bone marrow metastasis